Inflammatory Bowel Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Inflammatory Bowel Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Report Format: PDF+Excel | Report ID: SR112023A6691
Buy Now

The inflammatory bowel disease market has been comprehensively analyzed in IMARC’s new report titled “Inflammatory Bowel Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”. Inflammatory bowel disease (IBD) is a term mainly used to describe two disorders, Crohn’s disease and ulcerative colitis, that are characterized by the chronic inflammation of the gastrointestinal tract. It tends to occur in the case of genetically susceptible individuals after an exaggerated immune response to a normal stimulus comprising food and intestinal flora. Inflammatory bowel disease symptoms tend to vary, depending on the severity of inflammation and the region where it occurs. The signs and symptoms that are observed in Crohn’s disease and ulcerative colitis comprise diarrhea, fatigue, abdominal pain and cramping, blood in the stool, reduced appetite and unintended weight loss, mouth sores, pain or drainage near and around the anus owing to infection from a tunnel into the skin (fistula), etc. The diagnosis of IBD requires a combination of clinical and imaging findings, inflammatory laboratory markers, and endoscopic biopsies. The hematological findings will include microcytic anemia, leukocytosis, and thrombocytosis. In the case of a positive result, inflammatory markers such as erythrocyte sedimentation rate (ESR) and high-sensitivity C-reactive protein (hsCRP) are elevated.

The increasing prevalence of inflammatory gastrointestinal disorders owing to several associated factors, such as genetic predisposition, environmental triggers, immune system disturbances, etc., is primarily driving the inflammatory bowel disease market. In addition to this, the widespread adoption of various diagnostic procedures, including comprehensive metabolic panels, serologic markers, inflammation markers, etc., for early diagnosis of the disease is further propelling the market growth. Moreover, the escalating utilization of corticosteroids as the first line of treatment and their easy availability at retail pharmacy stores are also acting as significant growth-inducing factors. Apart from this, the emerging popularity of biologic and biosimilar drugs over traditional treatment options owing to their enhanced efficacy is further bolstering the global market. Additionally, the growing usage of pre-biotic and pro-biotic food products to improve gut health is also creating a positive outlook for the market. Besides this, the ongoing development of novel therapies with a better clinical profile and a patient-friendly RoA (route of administration) is further augmenting the global market. Numerous other factors, including the escalating utilization of single-cell RNA analysis to understand the molecular basis of the disease and the rising penetration of targeted and advanced therapies, are expected to drive the inflammatory bowel disease market in the coming years.

IMARC Group’s new report provides an exhaustive analysis of the inflammatory bowel disease market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for inflammatory bowel disease and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the inflammatory bowel disease market in any manner.

Time Period of the Study

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033
     

Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the inflammatory bowel disease market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the inflammatory bowel disease market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs
     

This report also provides a detailed analysis of the current inflammatory bowel disease marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Regulatory Status
     

Key Questions Answered in this Report

Market Insights

  • How has the inflammatory bowel disease market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the inflammatory bowel disease market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the inflammatory bowel disease market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the size of the inflammatory bowel disease patient pool (2017-2022) across the seven major markets?
  • What would be the forecasted patient pool (2023-2033) across the seven major markets?
  • What are the key factors driving the epidemiological trend of inflammatory bowel disease?
  • What will be the growth rate of patients across the seven major markets?
     

Inflammatory Bowel Disease: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for inflammatory bowel disease drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the inflammatory bowel disease market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Inflammatory Bowel Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Clients Testimonial

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More